Search Result "CEP-701"
Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 1867-1883
Author(s): Dirk Schmidt-Arras, Joachim Schwable, Frank- D. Bohmer, Hubert Serve
FLT3 as a Therapeutic Target in Childhood Acute Leukemia
Journal: Current Drug Targets
Volume: 8 Issue: 6 Year: 2007 Page: 703-714
Author(s): Matthew C. Stubbs, Scott A. Armstrong
JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 9 Year: 2013 Page: 1147-1161
Author(s): J. Trelinski,T. Robak
Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 2 Year: 2006 Page: 2609-2622
Author(s): Philip Lazarovici, Cezary Marcinkiewicz, Peter I. Lelkes
Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia
Journal: Current Cancer Therapy Reviews
Volume: 9 Issue: 3 Year: 2013 Page: 181-219
Author(s): Ugo Testa
Staurosporine Analogues from Microbial and Synthetic Sources and Their Biological Activities
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 31 Year: 2013 Page: 3872-3902
Author(s): B. S. Park,A. Z. Abdel-Azeem,M. M. Al-Sanea,K. H. Yoo,J. S. Tae,S. H. Lee
Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 3 Year: 2011 Page: 354-366
Author(s): Riccardo Masetti, Katharina Kleinschmidt, Carlotta Biagi, Andrea Pession
Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia
Journal: Current Cancer Therapy Reviews
Volume: 4 Issue: 1 Year: 2008 Page: 31-49
Author(s): Ugo Testa
Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1775-1784
Author(s): L. De Santi, G. Polimeni, S. Cuzzocrea, E. Esposito, E. Sessa, P. Annunziata, P. Bramanti
Mixed Lineage Kinase Family, Potential Targets for Preventing Neurodegeneration
Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 2 Issue: 2 Year: 2002 Page: 143-155
Author(s): Anna C. Maroney, Michael S. Saporito, Robert L. Hudkins